Bernstein Liebhard LLP is now actively filing product liability cases involving the alleged link between proton pump inhibitors and serious kidney complications.

On August 26th, the Firm filed a Nexium lawsuit in the U.S. District, Eastern District of New York, on behalf of an Illinois man who allegedly developed chronic kidney disease to due his use of the popular heartburn drug. The complaint accuses AstraZeneca of failing to warn patients and doctors that Nexium could potentially harm the kidneys, despite having knowledge of numerous reports involving proton pump inhibitor patients who had developed chronic kidney disease and other serious renal problems. (Case No. No. 16-04801)

What Are Proton Pump Inhibitors

Proton pump inhibitors are indicated for the short-term treatment of GERD and other digestive ailments associated with the excess production of gastric acid. Nexium and its counterparts, including Prilosec and PrevAcid, are among the most popular prescription drugs currently on the market, and were used by more than 15 million Americans in 2013. However, it is believed that up to 70% of these prescriptions lacked an appropriate indication.

A number of over-the-counter proton pump inhibitors are also available, including Nexium 24HR, Prilosec OTC and PrevAcid 24HR.

Because these medications are so ubiquitous, many believe that proton pump inhibitors can be taken without risk. However, the long-term use of these drugs has been linked to a number of serious side effects, including certain types of bone fractures, B12 deficiency, and low magnesium levels.

Proton Pump Inhibitors and the Kidneys

Recently, several studies have suggested that drugs like Nexium might be associated with the development of chronic kidney disease, kidney failure and acute kidney injury. In 2014, the U.S. Food & Drug Administration (FDA) ordered that the labeling for prescription proton pump inhibitors be updated to include mention of acute interstitial nephritis, a type of drug-induced kidney inflammation that can progress to chronic kidney disease and renal failure if not recognized and treated in a timely manner.

Last month, Bloomberg Law reported that several other complaints similar to the Nexium lawsuit filed by Bernstein Liebhard LLP were pending in New Jersey federal court. Dan Burke, a partner with the Firm, told Bloomberg Law that his office had received hundreds of inquiries, and that additional cases are currently under review.

Bernstein Liebhard LPP is offering free, no-obligation legal reviews to individuals who may have developed kidney problems related to the use of prescription or over-the-counter proton pump inhibitors. To obtain your case consultation, please call 877-779-1414.

Published September 20, 2016 by